NEU 2.44% $13.01 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-191

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,478 Posts.
    lightbulb Created with Sketch. 872
    Yes it's not as straightforward as 50% or 90%. At 50% you basically have control as you can pass ordinary resolutions. At 75% you can pass special resolutions. As long as you still meet your fiduciary duty in the process this could see your asset sold to the predator/majority shareholder or similar. I would still expect a revised uplifted offer would go to minority holders if less than 90% take initial offer but definitely no guarantee of that.
    Last edited by nashezz: 29/04/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.